Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02355171 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Personalize My Treatment (PMT) Registry

Study acronym: PMT
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Recruiting to Suspendedv23
  2. Trial status: Withdrawn to Recruitingv5
  3. Trial status: Not Yet Recruiting to Withdrawnv4
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The 'Personalize My treatment' (PMT) platform is a novel form of biobanking in which cancer patients willingly consent to provide residual, clinical samples (surplus after diagnostic testing) of their tumors for cancer research, to give access to their medical record for data collection and then followed prospectively throughout the trajectory of their illness. They further willingly consent to be recontacted for being informed of other research projects, including clinical trials.
Trial Details
NCT Number NCT02355171
Lead Sponsor Sir Mortimer B. Davis - Jewish General Hospital
Collaborators: Lady Davis Institute, McGill Centre for Translational Research in Cancer
Conditions
(from sponsor)		 Cancer
Related terms Neoplasms
Enrollment 20,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov